CCO Infectious Disease Podcast

Simplified HCV Screening and Care in People Who Use Drugs

Episode Summary

In this episode, Drs. Trooskin and Sulkowski, along with patient advocate Ronni Marks, discuss how to overcome barriers to HCV testing and treatment in the priority population of people who use drugs. Listen as they discuss the strategy of extending care to where people who use drugs are already receiving other services.

Episode Notes

In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:

• Screening recommendations
• Strategies to improve HCV screening
• HCV testing
• Treatment goals
• Strategies to improve HCV treatment uptake

Presenters:

Stacey B. Trooskin, MD, PhD, MPH
Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Ronni Marks
Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
Patient Advocate
New York, New York

Link to full program:
https://bit.ly/4grbwPT